Definition and epidemiology
Botulism is a neuroparalytic syndrome caused by botulinum neurotoxin (BoNT), one of the most potent toxins known, produced by the anaerobic, spore-forming bacterium Clostridium botulinum (and rarely related Clostridium species).
It is rare in developed countries, with most national surveillance systems reporting only a few hundred cases per year in the US, the majority of which are infant botulism. There are several clinically distinct forms:
- Foodborne botulism - toxin ingested in improperly preserved or home-canned food
- Infant botulism - most common form in the US; spores ingested (classically from honey or soil) germinate in the infant gut and produce toxin in situ
- Wound botulism - toxin produced by C. botulinum contaminating a wound, strongly associated with injection drug use (black tar heroin)
- Iatrogenic botulism - from cosmetic or therapeutic botulinum toxin injections, rare and usually with excessive dosing
- Adult intestinal colonization botulism - rare, analogous to infant form but in adults with altered gut flora or anatomy
- Botulinum toxin cleaves SNARE proteins, blocking presynaptic ACh release at the neuromuscular junction
- Classic presentation: descending, symmetric flaccid paralysis with cranial nerve findings and no sensory loss
- Infant botulism classically linked to honey ingestion; constipation is often the earliest sign
- EMG shows incremental response to repetitive high-frequency nerve stimulation
- Diagnosis is clinical; treat with antitoxin before waiting for confirmatory testing
- Avoid aminoglycosides and clindamycin in wound botulism; they can worsen neuromuscular blockade
- Antibiotics are not routinely given in foodborne/infant botulism due to theoretical toxin release risk
- Respiratory failure from diaphragmatic weakness is the major cause of death
Etiology and risk factors
The causative agent is Clostridium botulinum, a gram-positive, anaerobic, spore-forming rod. Spores are heat-resistant and ubiquitous in soil; the neurotoxin itself is heat-labile and destroyed by adequate cooking.
Risk factors by type
- Foodborne: home canning, fermented or smoked fish, improperly stored low-acid foods (toxin forms in anaerobic, low-acid, low-salt environments)
- Infant: age under 12 months (immature gut flora), honey ingestion, environmental spore exposure
- Wound: injection drug use, especially subcutaneous ("skin popping") or intramuscular injection of contaminated drugs
- Iatrogenic: therapeutic or cosmetic botulinum toxin injections, especially off-label high-dose use
Seven toxin serotypes exist (A-G); types A, B, E, and rarely F cause human disease.
Pathophysiology
Botulinum toxin is absorbed (from gut, wound, or injection site) into the bloodstream and taken up at peripheral cholinergic nerve terminals, particularly the neuromuscular junction and autonomic synapses.
The toxin is a zinc-dependent endopeptidase that cleaves SNARE proteins (SNAP-25, syntaxin, or VAMP/synaptobrevin depending on serotype), which are required for docking and fusion of acetylcholine-containing vesicles with the presynaptic membrane.
This presynaptic blockade of acetylcholine release prevents neuromuscular transmission, producing flaccid paralysis. Because the toxin does not cross the blood-brain barrier and does not affect sensory neurons, mental status and sensation remain intact (a key distinguishing feature). Autonomic cholinergic synapses are also affected, explaining dry mouth, blurred vision, and ileus. Recovery requires sprouting of new nerve terminals, which can take weeks to months.
Clinical features
Classic presentation is descending, symmetric flaccid paralysis beginning with cranial nerves and progressing caudally, without sensory deficits and typically without fever.
Early (bulbar) findings
- Diplopia, ptosis, blurred vision, fixed/dilated pupils
- Dysarthria, dysphagia
- Facial weakness
Progression
- Descending symmetric weakness of neck, arms, trunk, then legs
- Deep tendon reflexes diminished or absent
- Respiratory muscle weakness leading to respiratory failure (major cause of death)
Autonomic features
- Dry mouth, constipation/ileus, urinary retention
- Orthostatic hypotension
Infant botulism specifics
- Constipation (often the first sign)
- Poor feeding, weak cry, lethargy
- Hypotonia ("floppy baby"), diminished gag/suck reflex
- Can mimic sepsis workup presentations
Sensorium remains clear throughout (patients are often fully alert even when paralyzed and unable to communicate), which is an important exam clue.
Diagnosis
Diagnosis is primarily clinical, based on the characteristic pattern of descending flaccid paralysis with cranial nerve involvement and no sensory loss; treatment should not be delayed for laboratory confirmation.
Confirmatory testing
- Mouse bioassay (toxin neutralization bioassay) on serum, stool, gastric contents, or suspect food - historic gold standard, largely replaced by newer methods
- PCR for toxin gene detection, increasingly used
- Stool culture for C. botulinum in infant and wound botulism
- Wound culture in wound botulism
Electrophysiology
- Electromyography (EMG): normal nerve conduction velocity, decreased amplitude of muscle action potentials, and characteristic incremental response to repetitive nerve stimulation at high frequency (distinguishes from myasthenia gravis, which shows decrement, and Lambert-Eaton, which shows increment similarly but in a different clinical context)
Supportive labs
- Edrophonium (Tensilon) test and CSF studies are typically normal/unhelpful, useful mainly to exclude myasthenia gravis and Guillain-Barre syndrome
- Public health authorities should be notified immediately given outbreak and bioterrorism implications
Differential diagnosis
| Condition | Key distinguishing feature |
|---|---|
| Guillain-Barre syndrome (Miller Fisher variant) | Ascending paralysis, elevated CSF protein without pleocytosis, often preceded by GI/respiratory infection |
| Myasthenia gravis | Fatigability, improves with rest, decremental EMG response, anti-AChR antibodies |
| Lambert-Eaton myasthenic syndrome | Associated with small cell lung cancer, incremental EMG response but proximal weakness improves with activity |
| Tick paralysis | Ascending paralysis, resolves after tick removal, no cranial nerve predominance initially |
| Stroke (brainstem) | Asymmetric findings, sensory involvement possible, acute onset |
| Organophosphate poisoning | Cholinergic excess (SLUDGE symptoms, miosis) rather than pure flaccid paralysis |
| Diphtheric polyneuropathy | History of pharyngitis, pseudomembrane, delayed neuropathy |
Management
Botulism is a medical emergency; management is largely supportive plus toxin neutralization, following CDC and WHO guidance.
Key steps
- Airway and respiratory support: close monitoring of respiratory function (vital capacity), early intubation and mechanical ventilation if forced vital capacity declines or bulbar weakness threatens airway protection
- Antitoxin administration: equine-derived heptavalent botulinum antitoxin (for adults and children) given as early as possible, ideally before laboratory confirmation, since antitoxin only neutralizes circulating toxin, not toxin already bound at nerve terminals
- Human-derived botulinum immune globulin (BabyBIG) is used specifically for infant botulism in the US
- Wound botulism: antitoxin plus wound debridement and antibiotics (penicillin or metronidazole) targeting C. botulinum; aminoglycosides and clindamycin should be avoided as they can potentiate neuromuscular blockade
- Supportive care: nutritional support (often enteral), DVT prophylaxis, bladder care, physical therapy during prolonged recovery
- Antibiotics are generally not given in foodborne or infant botulism unless treating secondary infection, since bacterial lysis could theoretically release more toxin
- Public health reporting and source investigation (food recall, outbreak tracing) is mandatory
Recovery depends on nerve terminal regeneration and may take weeks to several months; full recovery is expected in most treated patients.
Complications and prognosis
- Respiratory failure requiring prolonged mechanical ventilation is the leading cause of morbidity and mortality
- Aspiration pneumonia secondary to bulbar weakness and dysphagia
- Autonomic instability: labile blood pressure, ileus, urinary retention
- Prolonged hospitalization and rehabilitation, sometimes requiring weeks to months of ventilatory and nutritional support
- With prompt supportive care and antitoxin, case fatality rate is low (generally well under 10% in treated patients in resource-adequate settings), though it was much higher historically before modern ICU care
- Full neurological recovery is expected in the large majority of survivors since the toxin's effect is reversible with nerve terminal regeneration, but recovery can be slow
"DANG THE 4 D's" for cranial nerve findings - Diplopia, Dysarthria, Dysphagia, Dry mouth (plus Descending weakness) help recall the bulbar-first, descending pattern of botulism.
Practice questions
1. A 3-week-old infant is brought in with 2 days of poor feeding, weak cry, and constipation. On exam, the infant has hypotonia, a diminished gag reflex, and ptosis bilaterally. There is no fever. The mother reports giving the infant a small amount of honey to soothe teething-like fussiness. What is the most likely underlying mechanism?
2. A 45-year-old man who injects heroin subcutaneously presents with diplopia, dysarthria, and descending weakness over 24 hours. He is afebrile, alert, and oriented, with no sensory deficits. A puncture wound on his forearm appears mildly inflamed. Which of the following antibiotics should be avoided in his management due to a risk of worsening neuromuscular blockade?
3. A 60-year-old woman develops progressive diplopia, ptosis, and dysphagia one week after eating home-canned green beans. Electromyography shows normal nerve conduction velocities with an incremental response of muscle action potential amplitude on high-frequency repetitive nerve stimulation. Which of the following best explains this EMG finding?
Frequently asked questions
What causes botulism?
Botulism is caused by botulinum neurotoxin produced by Clostridium botulinum. It occurs through ingesting toxin-contaminated food (foodborne), spores germinating in an infant's gut (infant botulism), toxin produced in a contaminated wound (wound botulism, often linked to injection drug use), or rarely from excessive therapeutic/cosmetic toxin injections.
What are the first symptoms of botulism?
The earliest symptoms are usually cranial nerve related: blurred or double vision, drooping eyelids, slurred speech, and difficulty swallowing. In infants, constipation and poor feeding are often the first clues, followed by progressive floppiness (hypotonia) and weak cry.
How is botulism diagnosed?
Botulism is diagnosed primarily on clinical grounds based on descending flaccid paralysis without sensory loss or fever. Confirmation uses toxin detection in serum, stool, or food via bioassay or PCR, and EMG can show a characteristic incremental response to repetitive nerve stimulation, but treatment starts before confirmation.
Is botulism curable?
Yes, botulism is treatable and most patients recover fully with prompt antitoxin administration and supportive care, including ventilatory support if needed. Recovery can take weeks to months because nerve terminals must regenerate, but survival and full neurological recovery are expected in the large majority of properly treated cases.
Botulism vs Guillain-Barre syndrome — what is the difference?
Botulism causes descending paralysis starting with cranial nerves and no sensory involvement, due to toxin blocking acetylcholine release. Guillain-Barre syndrome typically causes ascending paralysis with possible sensory symptoms and elevated CSF protein, due to autoimmune peripheral nerve demyelination. EMG and CSF findings help distinguish the two.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: A05.1
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.